Tag: Investors

Filter

Thought Leadership

Product

Community

NantHealth
NantHealth Reports 2020 First Quarter Financial Results
Q1 Financial Highlights 2020 vs 2019: SaaS revenue was $18.1 million, up 2% Total gross margin increased to 60% from...
NantHealth
NantHealth
NantHealth to Report 2020 First-quarter Financial Results and Host Conference Call on Thursday, May 7
CULVER CITY, Calif.–(BUSINESS WIRE)–May 4, 2020– NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report...
NantHealth
NantHealth
NantHealth Reports 2019 Fourth-Quarter, Full-Year Financial Results
Q4 Financial Highlights 2019 vs 2018: Total revenue was $24.2 million, up 6% SaaS revenue was $18.4 million, up 6%...
NantHealth
NantHealth
NantHealth Reports 2019 Third-Quarter Financial Results
Q3 Financial Highlights: Total revenue was $22.4 million SaaS revenue was $18.3 million, up 15% from Q3 2018 Total gross...
NantHealth
NantHealth
NantHealth to Report 2019 Third-Quarter Financial Results and Host Conference Call on Thursday, November 7
Culver City, Calif. – October 30, 2019 — NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced...
NantHealth
NantHealth
NantHealth’s Eviti Platform Again Granted Full URAC Accreditation, Through September 1, 2022
This designation reaffirms that NantHealth is a trusted leader in utilization review and is committed to quality and transformative healthcare,...
NantHealth
NantHealth
NantHealth Reports 2019 Second-Quarter Financial Results
Q2 Financial Highlights: Fourth consecutive quarter of total revenue growth Total revenue was $25.7 million, up 17% from Q2 2018...
NantHealth
NantHealth
NantHealth to Report 2019 Second-Quarter Financial Results and Host Conference Call on Thursday, August 8
Culver City, Calif. – August 1, 2019 — NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced...
NantHealth
Precision Insights
NantCell Announces New Celgene Investment
Immunotherapy Company Will Present Findings at the JP Morgan Healthcare Conference in San Francisco on January 7th Second Round Crossover Funding...
Precision Insights
NantHealth
NantHealth Reports 2018 Third-Quarter Financial Results
Total Revenue in Q3 was $22.3 Million SaaS revenue of $15.9 million in Q3, up 5% from $15.2 million in...
NantHealth
NantHealth
NantHealth to Report 2018 Third-Quarter Financial Results and Host Conference Call on Thursday, November 15
–Slight Delay in Reporting Financial Results, Due to Effects of Hurricane Michael– CULVER CITY, Calif. – (November 6, 2018) —...
NantHealth
NantHealth
NantHealth Reports 2017 Fourth-Quarter and Full-Year Financial Results
Total Q4 Revenue of $22.3 Million, Up 25% from $17.8 Million in Prior Year Q4 SAAS Revenue of $15.8 Million...
NantHealth